Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:GATX
NYSE:GATXTrade Distributors

Assessing GATX (GATX) Valuation As Recent Momentum Meets Conflicting Fair Value Signals

GATX stock in focus GATX (GATX) is drawing investor attention after recent share price moves, with the stock last closing at $189.13. That price sits alongside solid trailing returns and fresh fundamental data now available. See our latest analysis for GATX. Recent momentum has been firm, with a 7.5% 1 month share price return and a 21.3% 3 month share price return, contributing to a 3 year total shareholder return of 78.3%. This suggests strengthening sentiment rather than fading...
NYSE:CLX
NYSE:CLXHousehold Products

Assessing Clorox (CLX) Valuation As Shares Show Fresh Short Term Momentum

Why Clorox (CLX) is back on many investors’ radar Clorox (CLX) has caught fresh attention after recent trading, with the stock now around $119.59 and showing positive returns over the past month and past 3 months. See our latest analysis for Clorox. Recent trading has added to that momentum, with a 30 day share price return of 12.62% and a 90 day share price return of 13.86%, even though the 1 year total shareholder return is still a 15.39% decline. This mix of shorter term strength and...
TSX:EQB
TSX:EQBBanks

Assessing EQB (TSX:EQB) Valuation After The Transformative PC Financial Acquisition

EQB’s PC Financial Deal Reshapes Its Growth Story EQB (TSX:EQB) is back in focus after its acquisition of PC Financial, a move that reshapes the bank’s business model by adding a large new client base and broad cross-selling potential. See our latest analysis for EQB. EQB’s recent PC Financial deal comes on top of a strong run in the shares, with a 90 day share price return of 34.3% and a 5 year total shareholder return of 128.23% hinting that momentum has been building over time. If this...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Is It Too Late To Consider Intel (INTC) After A 154% One Year Surge?

For investors wondering whether Intel at US$50.24 is still reasonably priced or if most of the easy gains are already behind it, this article walks through what the current numbers are really saying about the stock. Over the short term, Intel has returned 2.9% over the last 7 days and 10.3% over the last 30 days. Its year to date return is 27.6% and its 1-year return is 154.1%, compared to 80.3% over 3 years and a 10.6% decline over 5 years. These mixed return figures sit against a backdrop...
NYSE:GHC
NYSE:GHCConsumer Services

Assessing Graham Holdings (GHC) Valuation As Shares Trade On A Low P/E And DCF Suggests Upside

Why Graham Holdings (GHC) Is On Investors’ Radar Today Graham Holdings (GHC) has drawn attention after recent share price moves, with the stock closing at $1,118.60. That puts fresh focus on how its diversified operations and current return profile fit into long term portfolios. See our latest analysis for Graham Holdings. While the latest 3.42% one day share price decline and softer 7 day and 30 day share price returns may hint at cooling short term momentum, Graham Holdings still shows...
NasdaqGS:SOHU
NasdaqGS:SOHUEntertainment

Sohu.com (SOHU) Returns To Profit In Q3 EPS Turnaround Tests Volatility Concerns

Sohu.com (SOHU) just posted its FY 2025 third quarter numbers, with revenue of US$180.2 million, basic EPS of US$0.32 and net income excluding extra items of US$8.7 million setting the tone for the latest update. The company has seen revenue move from US$151.9 million in Q3 2024 to US$180.2 million in Q3 2025, while basic EPS shifted from a loss of US$0.52 to a profit of US$0.32. This gives investors a cleaner read on how margins are shaping up after a volatile run of results. See our full...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

EU Antitrust Move Targeting WhatsApp AI Access Could Be A Game Changer For Meta Platforms (META)

In early February 2026, European Union competition regulators formally charged Meta Platforms with breaching antitrust rules by excluding rival artificial intelligence assistants from its WhatsApp messaging service, and signaled they may impose interim measures to prevent what they view as serious and irreparable harm to competition. The case puts WhatsApp’s Business API at the center of a broader fight over how much control a dominant messaging platform should have over access for...
NYSE:CLF
NYSE:CLFMetals and Mining

Cleveland Cliffs (CLF) Quarterly Loss Extends Unprofitable Narrative Despite US$4.7b Q3 Revenue

Cleveland Cliffs (CLF) just posted its FY 2025 numbers with Q3 revenue of US$4.7b and a basic EPS loss of US$0.50, alongside trailing twelve month revenue of US$18.6b and a basic EPS loss of US$3.40. Over recent quarters the company has seen revenue move between US$4.3b and US$5.2b while basic EPS has ranged from a small loss of roughly US$0.00 to a loss of US$1.00 per quarter, setting a mixed backdrop for how you read this latest print. With the shares at US$12.31, investors are likely to...
NYSE:PFE
NYSE:PFEPharmaceuticals

How Obesity Pipeline Gains And TrumpRx Move At Pfizer (PFE) Have Changed Its Investment Story

In early February 2026, Pfizer reported mixed 2025 financial results, reaffirmed 2026 revenue guidance, highlighted progress in its GLP-1 obesity pipeline, secured FDA Priority Review to expand HYMPAVZI’s hemophilia indication, and joined the TrumpRx drug pricing platform with discounted access to more than 30 medicines. Together, these developments underscore how Pfizer is trying to offset patent expiries and waning COVID-19 revenues by building new specialty and obesity franchises while...
NYSE:DT
NYSE:DTSoftware

Dynatrace (DT) Margins Reach 27.3% Putting Pressure On Bearish Profitability Narratives

Dynatrace (DT) just posted its Q3 2026 scorecard with recent quarterly revenue running at about $493.8 million and Basic EPS of roughly $0.19, set against a trailing 12 month picture that includes Basic EPS of $1.69 and revenue of about $1.9 billion, plus earnings growth in the dataset of 210.1% over the past year. The company has seen revenue move from $399.2 million in Q1 2025 to $493.8 million in Q2 2026 and quarterly Basic EPS shift from $0.13 to $0.19 over the same period. Year long...
NYSE:WAT
NYSE:WATLife Sciences

Waters (WAT) Margins Hold Near 21% As Bullish Growth Narratives Face a Reality Check

Waters (WAT) FY 2025 earnings snapshot Waters (WAT) reported Q3 FY 2025 revenue of US$799.9 million and basic EPS of US$2.50, with trailing 12 month EPS of US$10.91 on revenue of about US$3.1 billion. The company’s quarterly revenue rose from US$708.5 million in Q2 2024 to US$771.3 million in Q2 2025, and then to US$799.9 million in Q3 2025. Over the same periods, basic EPS moved from US$2.41 to US$2.47 and then to US$2.50, highlighting a story focused on consistent earnings and resilient...
NasdaqGS:MDLN
NasdaqGS:MDLNMedical Equipment

Is Medline (MDLN) Fairly Priced After Recent Share Price Momentum

This article examines whether Medline, at around US$47.37, is trading at fair value or something more compelling, and explores what the current price might be indicating. Over shorter time frames, the stock has returned 5.2% over the last week, 16.9% over the last 30 days and 16.6% year to date. These moves may have drawn the attention of investors who follow momentum and shifts in risk sentiment. Recent news about Medline has focused on its position in the healthcare space and how investors...